RIYADH,Saudi Arabia,Sept. 9,2024 -- The Saudi Authority for Data and Artificial Intelligence (SDAIA) will hold a press conference on Sunday,September 8,at the King Abdulaziz International Conference Center. The press conference will highlight key aspects of the upcoming third edition of the Global AI Summit,taking place under the patronage of His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud,Crown Prince,Prime Minister,and Chairman of SDAIA's Board of Directors. The summit is scheduled for September 10-12,2024,and will feature over 300 speakers,attracting global thought leaders,policymakers,and AI experts from more than 100 countries.
The press conference will feature remarks from prominent figures,including H.E. Dr. Abdullah bin Sharaf Alghamdi,President of SDAIA,H.E. Dr. Esam bin Abdullah Alwagait,Director of the National Information Center (NIC),and H.E. Dr. Yaser bin Mohammed Al-Onaizan,CEO of the National Center for AI (NCAI) in SDAIA.
Key topics to be covered during the press conference will include the significance of the Crown Prince's patronage,the summit's focus areas,and its anticipated impact on the good of humanity,particularly amid the rapid development of AI technologies. It will also showcase how AI is driving economic growth,creating new sectors and industries,and addressing global challenges. Furthermore,the press conference will spotlight Saudi Arabia's leadership in promoting responsible AI use and ethics on the international stage,while addressing both the opportunities and challenges AI presents.
For more information about the GAIN Summit,please visit: https://globalaisummit.org/en/default.aspx
Forest City’s 9th Anniversary: A Vision Realized, A Future Unfolding
MEXC Launches March Futures Competition with Prize Pool of Up to 8 Million USDT
Green financial technology, GECC carbon assets, the code of green wealth!
China’s Economic Vitality Through Tax Data
Restaurant Week Spring 2025 in China: Savor Michelin and Black Pearl Menus in China with UnionPay International
Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership
©copyright 2009-2020 Singapore Info Map